Altered development of dopaminergic cells in the retina of weaver mice

Author(s):  
Claudine Savy ◽  
Elisabeth Martin-Martinelli ◽  
Axelle Simon ◽  
Charles Duyckaerts ◽  
Catherine Verney ◽  
...  
2019 ◽  
Vol 17 (4) ◽  
pp. 290-303
Author(s):  
Sangsang Li ◽  
Yanfei Li ◽  
Bingpeng Deng ◽  
Jie Yan ◽  
Yong Wang

Background: The abuse of psychostimulants such as methamphetamine (METH) is common in human immunodeficiency virus (HIV)-infected individuals. Acquired immunodeficiency syndrome (AIDS) patients taking METH and antiretroviral drugs could suffer severe neurologic damage and cognitive impairment. Objective: To reveal the underlying neuropathologic mechanisms of an HIV protease inhibitor (PI) combined with METH, growth-inhibition tests of dopaminergic cells and RNA sequencing were performed. Methods: A combination of METH and PI caused more growth inhibition of dopaminergic cells than METH alone or a PI alone. Furthermore, we identified differentially expressed gene (DEG) patterns in the METH vs. untreated cells (1161 genes), PI vs. untreated cells (16 genes), METH-PI vs. PI (3959 genes), and METH-PI vs. METH groups (14 genes). Results: The DEGs in the METH-PI co-treatment group were verified in the brains of a mouse model using quantitative polymerase chain reaction and were involved mostly in the regulatory functions of cell proliferation and inflammation. Conclusion: Such identification of key regulatory genes could facilitate the study of their neuroprotective potential in the users of METH and PIs.


2014 ◽  
Vol 39 (4) ◽  
pp. 707-718 ◽  
Author(s):  
Se-Eun Park ◽  
Kumar Sapkota ◽  
Jun-Hui Choi ◽  
Myung-Kon Kim ◽  
Young Hoi Kim ◽  
...  

2008 ◽  
Vol 106 (1) ◽  
pp. 405-415 ◽  
Author(s):  
Dong Hee Choi ◽  
Eun-Mee Kim ◽  
Hyo Jin Son ◽  
Tong H. Joh ◽  
Yoon Seong Kim ◽  
...  

2005 ◽  
Vol 94 (6) ◽  
pp. 1685-1695 ◽  
Author(s):  
Charleen T. Chu ◽  
Jian-hui Zhu ◽  
Guodong Cao ◽  
Armando Signore ◽  
Suping Wang ◽  
...  

2018 ◽  
Vol 129 ◽  
pp. 394-406 ◽  
Author(s):  
Juan A. Parga ◽  
Ana I. Rodriguez-Perez ◽  
Maria Garcia-Garrote ◽  
Jannette Rodriguez-Pallares ◽  
Jose L. Labandeira-Garcia

2021 ◽  
Author(s):  
Chaimaa Kinane ◽  
Hugo Calligaro ◽  
Antonin Jandot ◽  
Christine Coutanson ◽  
Nasser Haddjeri ◽  
...  

AbstractDopamine (DA) plays a critical role in retinal physiology, including resetting of the retinal circadian clock that in turn regulates DA release. DA acts on major classes of retinal cells by reconfiguring electrical and chemical synapses. Although a bidirectional regulation between intrinsically photosensitive melanopsin ganglion cells (ipRGCs) and dopaminergic cells has been demonstrated during development and adulthood, DA involvement in the ontogeny of the retinal clock is still unknown.Using wild-typePer2Lucand melanopsin knockout (Opn4-/-::Per2Luc) mice at different postnatal stages, we found that the retina can generate self-sustained circadian rhythms from postnatal day 5 that emerge in the absence of external time cues in both genotypes. Intriguingly, DA lengthens the endogenous period only in wild-type retinas, suggesting that this desynchronizing effect requires melanopsin. Furthermore, blockade of cholinergic retinal waves in wild-type retinas induces a shortening of the period, similarly toOpn4-/-::Per2Lucexplants. Altogether, these data suggest that DA desynchronizes the retinal clock through a melanopsin-dependent regulation of acetylcholine retinal waves, thus offering a new role of melanopsin in setting the period of the retinal clock during development.


Sign in / Sign up

Export Citation Format

Share Document